Gut Disease Nutrition Therapy: IBS, IBD, SIBO

Microbiota-focused 12-week nutrition therapy for IBS, IBD, SIBO, and leaky gut.
Reviewed by Dyt. Şeyda Ertaş, Registered Dietitian Last reviewed: May 24, 2026
Gut Disease Nutrition Therapy: IBS, IBD, SIBO

Quick answer: Gut disease nutrition therapy supports microbiota balance, mucosal repair, and symptom management for IBS, IBD, and SIBO. This structured approach utilizes a 3-phase low FODMAP protocol, the 5R restorative framework, and targeted supplementation like 5 g/day glutamine or 75 mg zinc carnosine. By addressing inflammation and bacterial overgrowth, a personalized 12-week plan helps reduce flare frequencies and improves daily digestive comfort in coordination with your gastroenterologist.

Do morning abdominal cramps, variable bowel habits, gas, and bloating worsen during the day? Gut disease nutrition therapy provides a structured path to relief when medication alone is not enough. In my clinical experience, I observe that clients who integrate targeted nutrition protocols with their gastroenterology treatments achieve the most sustainable symptom management. Evidence-based strategies can reduce IBS symptoms by 50-70 percent in 4-6 weeks and IBD flare frequency by 30-40 percent annually.

This therapy combines a 3-phase low FODMAP elimination (strict restriction → reintroduction → personalization), Mediterranean and Specific Carbohydrate Diet (SCD) options for IBD, bacterial starvation protocols for SIBO, microbiota-supportive probiotics, and mucosal repair supplements. I provide online guidance grounded in endoscopy, biopsy, and breath test data to ensure a highly personalized and effective approach.

Who Is Gut Disease Nutrition Therapy For?

  • Adults with IBS (irritable bowel syndrome): Rome IV criteria; IBS-D (diarrhea predominant), IBS-C (constipation predominant), IBS-M (mixed), IBS-U subtypes — needing subtype-specific planning grounded in an IBS diet
  • Adults with IBD (inflammatory bowel disease): Crohn's disease, ulcerative colitis; those in flare or remission, those on biologic therapy (anti-TNF, vedolizumab)
  • Adults with SIBO (small intestinal bacterial overgrowth): Glucose or lactulose breath test positive; methane dominant or hydrogen dominant subtypes
  • Suspected leaky gut (intestinal permeability) syndrome: Autoimmune coexistence (Hashimoto's, rheumatoid arthritis, celiac), chronic fatigue, food intolerances — needing a leaky gut protocol
  • Adults with diverticular disease: Diverticulitis flare or post-flare follow-up; low-fiber acute → high-fiber maintenance planning
  • Post-antibiotic microbiota disruption: Chronic bloating, stool changes, or C. difficile history after broad-spectrum antibiotics

Start your personalized diet program today!

Book Online

The 3 Core Challenges: IBS + IBD + SIBO

IBS is a functional bowel disorder; endoscopy may look normal yet symptoms are real and severe. Mechanism: gut-brain axis dysregulation, visceral hypersensitivity, microbiota imbalance. Management: low FODMAP strict elimination for 6-8 weeks → controlled reintroduction → personalization. Stress management, hypnotherapy, and probiotics (Bifidobacterium infantis 35624) are added tools. About 75 percent of IBS patients show a clear FODMAP response.

IBD is an immune-mediated chronic inflammatory condition; Crohn's (entire digestive tract, transmural) and ulcerative colitis (colon only, mucosal) are the two main types. Nutrition strategy differs between flare and remission: in flare, enteral nutrition (especially effective in pediatric Crohn's), low fiber, low residue; in remission, Mediterranean pattern with optional structured diets (SCD or Crohn's Disease Exclusion Diet). Iron, B12, vitamin D, zinc, and folic acid deficiencies are screened; biologic dosing and infection risk are kept in view.

SIBO is excess bacterial colonization in the small intestine; immediate post-meal bloating, gas, diarrhea/constipation. Diagnosis: glucose or lactulose breath test (hydrogen + methane). Treatment: rifaximin (classic), plant-based antimicrobials (allicin, oregano oil) as alternatives; followed by microbiota repair. Nutrition: Cedars-Sinai Low FODMAP-SIBO or Bi-Phasic protocols; strict elimination for 2-4 weeks. Recurrence is high (30-50 percent); underlying motility or structural issues are investigated.

What the Therapy Covers

  • 3-phase low FODMAP protocol: Strict elimination (6-8 weeks) → reintroduction (8-12 weeks, each FODMAP group tested) → personalization (long-term liberalized plan)
  • 5R restorative protocol: Remove (trigger foods), Replace (missing enzymes), Reinoculate (probiotic + prebiotic), Repair (glutamine, zinc carnosine, omega-3), Rebalance (stress, sleep, circadian)
  • IBD flare vs remission planning: Low residue + EEN (exclusive enteral nutrition) option during flare; Mediterranean + SCD/CDED variants during remission
  • SIBO antibacterial + microbiota repair: Restricted fiber/fermentation during elimination; motility agents and low-dose naltrexone discussed for recurrences
  • Probiotic strain selection: B. infantis 35624 + L. plantarum 299v in IBS; VSL#3 or multi-strain combinations in IBD remission; S. boulardii post-antibiotic — personalized to condition
  • Mucosal repair supplements: Glutamine 5 g/day, zinc carnosine 75 mg, omega-3 (EPA+DHA) 2-3 g, curcumin 500-1,500 mg; vitamin D 30-50 ng/mL target (modulates inflammation in IBD)

3 Stages of the Therapy

Stage 1 — Assessment (Week 0-1)

Endoscopy/colonoscopy report, biopsy results, blood work (CRP, ESR, calprotectin, CBC, B12, vitamin D, ferritin, zinc, magnesium), stool calprotectin, breath test (for SIBO), medication list, and symptom diary are reviewed together. During the 60-minute online consultation, the sub-protocol matching the underlying condition is selected.

Stage 2 — Personal Plan (Week 1-12)

A low FODMAP / 5R / IBD-specific plan, probiotic schedule, mucosal repair supplements, and trigger food diary are structured. Bi-weekly follow-ups review symptom scores, stool form (Bristol scale), energy levels, and sleep.

Stage 3 — Maintenance (After Week 12)

Inflammation markers (CRP, calprotectin) are re-measured at month 3; in IBD, medication dose is reviewed together with gastroenterology. Monthly follow-ups and an annual full assessment are scheduled. The plan is dynamically updated for flares, hospitalization, or surgery (resection, ostomy).

Expected Results

  • IBS symptoms: 50-70 percent reduction in 4-6 weeks; clear improvement in bloating, cramps, and stool irregularity
  • IBD flare frequency and duration: 30-40 percent reduction in annual flare count; longer remission periods
  • Inflammation markers: CRP and calprotectin trend toward normal in 3-6 months; biologic therapy response improves
  • Micronutrient values: B12, iron, vitamin D, zinc, folic acid reach target ranges in 3 months
  • SIBO eradication success: 60-70 percent first-attempt eradication with diet + antimicrobial combination
  • Quality of life: Work attendance, comfort during social eating, anxiety-depression scores improve
  • Microbiota diversity: Alpha diversity increases with fiber variety + fermented food integration (measurable via stool microbiome testing)

Online Gut Disease Nutrition Counseling

A 12-week restorative gut nutrition plan is designed based on endoscopy-biopsy reports, breath test results, and laboratory values. FODMAP elimination, the 5R protocol, and probiotic strain selection run in coordination with gastroenterology follow-up.

Online Gut Disease Nutrition Counseling with Dietitian Şeyda Ertaş

Frequently Asked Questions

IBS is a functional disorder; while endoscopy results are normal, the symptoms are real (cramps, bloating, irregular stool). IBD is an organic inflammatory condition; Crohn's disease and ulcerative colitis present with bleeding and ulcers, and biopsies show inflammation. SIBO involves bacterial overgrowth in the small intestine; it is diagnosed via a breath test and often underlies IBS (testing positive in 30-78 percent of IBS patients). Treatment approaches differ: a low-FODMAP diet and stress management for IBS, immunosuppressants and a Mediterranean diet for IBD, and antimicrobials combined with dietary changes for SIBO. Consulting a gastroenterologist is essential for an accurate diagnosis.
The 3-phase protocol runs for a total of 12-16 weeks. Phase 1 (elimination) lasts 6-8 weeks, during which all fermentable carbohydrate groups are removed to evaluate symptom response. Phase 2 (reintroduction) spans 8-12 weeks, where each FODMAP group (fructose, lactose, polyols, fructans, and GOS) is tested individually. In Phase 3 (personalization), tolerated FODMAP groups are added back into the diet, while intolerant ones remain excluded. Strict elimination beyond 8 weeks disrupts microbiota diversity, making Phase 3 a lifelong maintenance strategy.
During a flare, the primary goal is to rest the gut and prevent undernutrition. A low-residue diet is recommended, which includes refined grains (white bread, white rice), well-cooked proteins (chicken breast, fish), peeled and cooked vegetables (zucchini, carrots), and ripe bananas; meanwhile, caffeine, alcohol, spices, and dairy are restricted. In pediatric Crohn's disease, exclusive enteral nutrition (EEN—formula only for 6-8 weeks) serves as an effective alternative to steroids. For adult Crohn's disease, the Crohn's Disease Exclusion Diet (CDED) combined with partial enteral nutrition may be recommended. Severe flares always require immediate medical attention from a physician.
Yes, they are different conditions. Celiac disease is an autoimmune disorder characterized by positive tissue transglutaminase IgA antibodies and villous atrophy on a biopsy, making a strict, lifelong gluten-free diet mandatory. Non-celiac gluten sensitivity (NCGS) yields negative test results, but symptoms such as cramps and brain fog still appear when gluten is consumed; its exact mechanism remains debated and is partly traceable to FODMAP fructans. Eliminating wheat helps approximately 30 percent of IBS patients. Celiac testing must be performed first while still consuming gluten, followed by a gastroenterology consultation before attempting any gluten-free trial.
No, their effectiveness is highly strain- and condition-specific. For IBS, Bifidobacterium infantis 35624 and Lactobacillus plantarum 299v are evidence-based options, whereas mixed probiotics show variable results. During IBD remission, the high-dose, 8-strain VSL#3 is effective for ulcerative colitis but has limited efficacy in Crohn's disease. The use of probiotics in SIBO remains debated, as they can sometimes increase fermentation. Following a C. difficile infection, S. boulardii is an evidence-based recommendation. Consuming yogurt, kefir, and fermented vegetables (such as sauerkraut and kimchi) provides natural microbiota support; a daily intake of 10-20 billion CFU is sufficient, and higher doses do not offer additional benefits.
The AIP diet is highly restrictive, completely eliminating grains, legumes, dairy, eggs, nightshades (such as eggplants, tomatoes, and peppers), nuts, alcohol, coffee, and sugar. It involves a 30-90 day elimination phase followed by a controlled reintroduction. There is limited clinical evidence supporting its use, primarily for Hashimoto's thyroiditis and IBD remission; however, the significant food restriction carries a risk of microbiota disruption. If followed improperly, it can lead to unintended weight loss, muscle wasting, and social isolation. Dietitian supervision is mandatory; the diet should not be sustained long-term and must eventually transition into a personalized nutritional plan.
In a healthy gut, a daily intake of 25-30 g of fiber increases microbiota diversity and produces short-chain fatty acids, particularly butyrate, which nourish the mucosa. During an IBD flare, however, the inflamed mucosa becomes irritated by fiber, leading to increased mechanical damage and higher stool frequency, making a low-residue diet necessary. During remission, fiber is reintroduced gradually, starting with soluble fiber (like oats and psyllium) and followed later by insoluble fiber (such as bran and raw vegetables). If a Crohn's disease stricture (narrowing) is present, a low-fiber diet may need to be permanent.
The gut-brain axis, involving the vagus nerve, HPA axis, and cytokines, facilitates multi-directional communication. Stress increases mucosal permeability by elevating zonulin levels, reduces microbiota diversity, and lowers the pain threshold. Furthermore, 50-70 percent of IBS patients experience comorbid anxiety or depression. Management strategies include cognitive behavioral therapy, hypnotherapy (which is evidence-based for IBS), mindfulness, yoga, and regular sleep. Because nutrition alone is insufficient, a multi-modal approach is necessary. An effective strategy integrates lifestyle modifications, nutritional changes, and psychiatric support together when needed.
Stool calprotectin is a highly specific marker for gut inflammation. Normal levels are under 50 mcg/g, while 50-200 mcg/g represents a gray zone, and anything over 200 mcg/g indicates active inflammation. This test is critical for distinguishing IBS from IBD, as levels remain normal in IBS; during IBD follow-ups, it can predict flares without requiring an endoscopy and effectively tracks treatment response. It is also more sensitive than blood CRP because it is gut-specific. Routine monitoring may involve measuring these levels every 3 months, as the trend over time matters more than a single reading. Since bleeding or antibiotic use can affect the results, professional interpretation by a physician is always required.
Broad-spectrum antibiotics can cause microbiota changes that last for 6-12 months, and certain bacterial strains, such as Bifidobacterium and Bacteroides, may disappear completely. An effective recovery strategy includes taking specific probiotics, like S. boulardii and Lactobacillus rhamnosus GG, during and for 4 weeks after the antibiotic treatment. It is also beneficial to gradually introduce prebiotic fibers, such as chicory inulin and FOS, while monitoring for gas production. Incorporating fermented foods like kefir, yogurt, sauerkraut, and kimchi, along with polyphenol-rich options like tea, cocoa, and berries, further supports recovery. In cases with a high risk of C. difficile infection, fecal microbiota transplantation (FMT) may be discussed, though this remains a decision for a gastroenterologist.
A healthy adult typically passes gas 13-21 times daily, producing a total volume of 500-1500 ml. Excess gas, defined as passing gas 50+ times a day, usually results from unfermented carbohydrates (FODMAPs), SIBO, poor chewing habits, swallowing air, or lactose and fructose intolerances. Management strategies include eating slowly, chewing food thoroughly, reducing the intake of chewing gum and carbonated drinks, and soaking legumes before cooking; additionally, simethicone can be used as a supportive, though not curative, measure. Foul-smelling gas often signals a microbiota imbalance or an excess of hydrogen sulfide, which may necessitate a formal investigation for SIBO.
A consultation is essential when alarm symptoms are present, such as bright red blood or melena in the stool, unintentional weight loss of 5+ kg in 6 months, abdominal pain that causes nighttime waking, or a combination of fever and diarrhea. Other critical indicators include a family history of colon cancer combined with being over 45 years of age, iron deficiency anemia, and elevated CRP or ESR levels. In these specific cases, dietary interventions are secondary; a colonoscopy, biopsy, and comprehensive laboratory testing must come first. Initial assessments should always screen for these alarm symptoms upfront, ensuring that individuals are urgently referred to a gastroenterologist whenever needed.
Dyt. Şeyda Ertaş

Dyt. Şeyda Ertaş

Expert Dietitian

Dietitian & Nutrition Specialist

BSc in Nutrition and Dietetics, Hacettepe University. Over 7 years of professional experience guiding 2000+ clients toward healthier lives through science-based nutrition.

View Profile

Free Pre-Application

This is a pre-application. No credit card required, payments determined after consultation.

Your personal data is processed within the scope of the GDPR Privacy Policy.

Application Received!

Your message has been sent successfully. We will contact you soon.

Working Hours

Monday - Friday: 09:00 AM - 6:00 PM
Saturday: 10:00 AM - 2:00 PM
Sunday: Closed

Applications received outside working hours or on holidays will be responded to on the next business day.

Working Hours:Mon-Fri: 9:00 - 19:00|Sat: 09:00 - 14:00
Contact Form